Cosmos Health Inc.

Cosmos Health Inc. (ticker: COSM) is an NASDAQ-listed wholesale-drugs, proprietaries & druggists' sundries company. DredgeCap's structured extraction of COSM's SEC filings surfaces 35 active risk signals, including 34 late-filing signals, and 1 auditor-change signal. COSM reported $65.27M in revenue and -$19.14M for the period ending 2025-12-31, with operating cash flow of -$8.45M. Cash and equivalents stood at $716K (up 127.1% year-over-year). Total assets of $65.48M exceed total liabilities of $47.05M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.

COSM Cash Runway

Months-of-runway analysis for COSM, derived directly from SEC XBRL: latest cash and operating cash flow, monthly burn rate, runway under current conditions. Historical trend + verbatim citation panel ships in Phase 2.

Coming in Phase 2

The dedicated per-ticker cash-runway page will surface a 6-8 quarter trend with the underlying us-gaap:CashAndCashEquivalentsAtCarryingValue + us-gaap:NetCashProvidedByUsedInOperatingActivities citations alongside each data point. In the meantime, see the ranked cross-company view:

All companies ranked by months-of-runway →

Related on COSM

Share-count dilution →

Dilution is the natural counterpart to runway burn.

Going-concern history →

Auditor + management language across filings.